Skip to main content
. Author manuscript; available in PMC: 2026 Mar 7.
Published in final edited form as: Am J Gastroenterol. 2025 Mar 7;120(11):2520–2528. doi: 10.14309/ajg.0000000000003383

Table 3.

Socio-demographic and clinical characteristics of those with persistent Barrett’s esophagus (BE) after ultrashort BE on index endoscopy compared to those with negative surveillance.

Persistent BE after USBE on Index Endoscopy 1
(n=86)
Negative BE after USBE on Index Endoscopy 2
(n=66)
p-value
Age at diagnosis (years) 61.5 [SD±8.9] 60.5 [SD±8.3] 0.480
Sex 1.000
 Male 81 (94.2%) 62 (93.9%)
 Female 5 (5.8%) 4 (6.1%)
Mean Follow Up Time (years) 5.85 [SD±10.0] 4.45 [SD±3.4] 0.277
BMI 0.368
 < 25 17 (19.8%) 14 (21.2%)
 25–29.9 34 (39.5%) 19 (28.8%)
 ≥30 35 (40.7%) 33 (50.0%)
Race/Ethnicity 0.011
 Non-Hispanic White 69 (80.2%) 44 (66.7%)
 Non-Hispanic Black 6 (7.0%) 16 (24.2%)
 Hispanic 11 (12.8%) 6 (9.1%)
Smoking Status 0.152
 Never smoker 17 (19.8%) 22 (33.3%)
 Former smoker 48 (55.8%) 29 (43.9%)
 Current smoker 21 (24.4%) 15 (22.7%)
Alcohol Status 0.280
 Never drinker 29 (33.7%) 27 (40.9%)
 Former drinker 16 (18.60%) 16 (24.2%)
 Current drinker 41 (47.7%) 23 (34.9%)
Hiatal Hernia 0.864
 No 34 (39.5%) 27 (40.9%)
 Yes 52 (60.5%) 39 (59.1%)
PPI or H2RA use 0.722
 No 20 (23.3%) 17 (25.8%)
 Yes 66 (76.7%) 49 (74.2%)
Biopsy Volume on index endoscopy (cm3) 0.03 [SD±0.03] 0.04 [SD±0.03] 0.156

Footnote:

1

Denotes surveillance sequence groups 1, 2 and 3.

2

Denotes surveillance sequence groups 4, 5 and 6.

Abbreviations: BE=Barrett’s esophagus.SD=standard deviation. BMI=body mass index. PPI=proton pump inhibitor. H2RA=H2 receptor antagonist.